RNAi-tech startup takes lead from psychotropics, medical cannabis veteran with new CEO pick 

October 20, 2022  |  Startland News Staff

Steve Meyer, RNAissance Ag

ST. LOUIS — Steve Meyer sees opportunity in RNAissance Ag — an offshoot Kansas City-grown TechAccel — especially its portfolio of safe biopesticides and novel RNAi manufacturing technology.

“I believe the full potential of RNAi-based solutions in agriculture is yet to be seen,” said Meyer, the company’s new CEO. “This innovative technology not only has the potential to offer a much-needed new tool to solve some of the toughest challenges we face in agriculture, but it also promises to revolutionize sustainable agriculture, making it safer for people and our planet.”

Meyer most recently was chief operating officer at Lucy Scientific Discovery Inc., British Columbia, a cGMP manufacturer of psychotropic compounds for therapeutic uses. Before that, he was the co-founder and CEO of Heya Wellness of St. Charles, Missouri, a vertically integrated medical cannabis firm.

RNAissance Ag, which is in the process of expanding its office and lab facilities at Bio Research Development and Growth (BRDG) Park in St. Louis, is a startup founded in 2019 by TechAccel based on a novel RNA-interference (RNAi) technology developed at the Donald Danforth Plant Science Center. RNAi is a technology that regulates gene expression without genetic modification.

Click here to read more about RNAissance Ag.

Kansas City-based TechAccel — a technology and venture development company investing in scientific breakthroughs for healthier plants, animals and foods — opened its facility at BRDG Park in 2021 to give RNAissance Ag and other initiatives room to grow, the company said previously.

Prior to his work with psychotropics and medical cannabis, Meyer worked for 16 years at Monsanto (now Bayer Crop Science) in a variety of scientific and commercial roles. He conducted biotechnology research that led to the development of multiple commercial products and played a key role in transforming the firm’s insect control discovery pipeline, leading to his appointment as a Monsanto Science Fellow.

Michael Helmstetter, TechAccel

“Steve has the expertise and leadership to drive the RNAissance Ag technology — both in biomanufacturing and biopesticide development — to commercial success,” said Michael Helmstetter, chairman of the board of directors for RNAissance Ag, as well as founder and president of TechAccel. “Plus, he has an innovator’s mindset and draws upon an extraordinary range of experiences and insights.”

Meyer’s announcement as CEO this week is effective immediately.

The primary focus of RNAissance Ag is the development of sprayable RNAi pesticides against pests such as the Diamondback Moth, Fall Armyworm and several others. RNAissance Ag pesticides are designed to be highly specific to the target pest, are not toxic to other organisms and are biodegradable. RNAissance Ag’s designs also have applications as pesticidal traits in crop seeds.

“I am excited and honored to join RNAissance Ag as its CEO,” Meyer said. “I am very impressed by the quality and caliber of the team, which is at the heart of every great company.”

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged , , ,
Featured Business
    Featured Founder

      2022 Startups to Watch

        stats here

        Related Posts on Startland News

        Video: Healthy workplace culture begins with intention, communication

        By Tommy Felts | October 26, 2017

        Editor’s note: This content was sponsored by Mid-Continent Public Library but independently produced by Startland News. Creating a healthy workplace culture must be done early and with intention, said Adrienne Haynes and Dwayne Lewis. To help startups develop a strategic human resource plan, Haynes, managing partner of SEED Law, and Dwayne Lewis, president of Lewis…

        From Google to KC, Beth Ellyn McClendon’s advice to startups: Test everything

        By Tommy Felts | October 26, 2017

        Don’t fall in love with an idea, Beth Ellyn McClendon said. “Test everything, especially your assumptions, and allow yourself to be persuaded by data,” said McClendon, a seed investor who formerly worked with Google, Android, YouTube, Cisco and Netscape. “Try to remember — tattoo it on your eyelids if you have to – anecdotes are not…

        Flo and Jamil Nelson, Bodyrite Fitness KC

        Bodyrite duo cooks meal prep into personal training concept

        By Tommy Felts | October 26, 2017

        Don’t just go with the flow at a traditional gym, Jamil Nelson said. Go with Flo. “Treadmills and ellipticals are pretty archaic to us,” said Nelson — or “Mr. Bodyrite” to his wife, Florese. “A jump rope is way better because it’s going to blow up your heart rate.” Modern workouts are all about functional,…

        Denise Kruse

        Denise Kruse: So your startup wants to be acquired – now what?

        By Tommy Felts | October 25, 2017

        Editor’s note: The opinions expressed in this commentary are the author’s alone. In the first column this three-part series, I discussed how a stellar strategy only gets your company halfway, but executing can take you to the finish line. Next, we took a deep dive into what startups should do after landing a first big…